New cardiac remote monitoring kit extends testing to two weeks

Canadian vendor, m-Health Solutions Inc., just debuted a new smartphone-based cardiac monitoring system that allows patients to track their cardiac rhythms over a full two weeks--far beyond the usual 24-hour period most in-home devices can handle.

Physicians attach the electrodes during an in-office visit, then send the patient home, officials told the Hamilton Spectator. Afterward, m-Health Solutions mails a kit with a smartphone that has the cardiac app loaded on it. The app monitors and tracks cardiac status for two full weeks, with the phone auto-sending data at predetermined times. At the end of the testing period, the patient detaches the phone and mails it back to m-Health for analysis, company officials explain.

The system runs on BlackBerry smartphones for now, although that shouldn't be a big surprise, given that Research In Motion's co-CEO Jim Balsillie sits on m-Health Solutions' board. No clear indications yet which other platforms m-Health will target next.

The company got a big thumbs-up from its government minders this week, however. Checking up on the $100,000 grant the government had awarded to m-Health Solutions, Canadian minister of state Gary Goodyear called the effort a "success story" and an example of how the government wants to continue to "commercialize new discoveries."

To learn more:
- read this post in the Hamilton Spectator

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.